First-in-human SRP-1005 Huntington's Disease Phase 1 Trial
Summary
NIH ClinicalTrials.gov registered a first-in-human Phase 1 trial (NCT07536061) studying SRP-1005, an investigational treatment for Huntington's Disease. The multi-center trial will evaluate the safety and tolerability of SRP-1005 versus placebo in participants with Huntington's Disease. The trial has an anticipated start date of April 17, 2026.
What changed
NIH registered a new first-in-human Phase 1 clinical trial on ClinicalTrials.gov for SRP-1005, an investigational drug for Huntington's Disease. The trial NCT07536061 is classified as Phase 1 and will study the effects of SRP-1005 against placebo in multiple centers.
For pharmaceutical sponsors and clinical investigators, this registration signals an emerging development program in Huntington's Disease. Patients and advocacy groups gain visibility into upcoming clinical research. The trial represents early-stage development with no immediate compliance obligations for external parties.
Archived snapshot
Apr 17, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease
Phase 1 NCT07536061 Kind: PHASE1 Apr 17, 2026
Abstract
This is a first-in-human, multi-center trial studying the effects of SRP-1005 in participants with Huntington's disease (HD).
Conditions: Huntington's Disease
Interventions: SRP-1005, Placebo
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.